Medical Care Technologies Inc. (OTCID:MDCE) Delivers Stronger Melanoma Scan Beta Readout on Expanded Human-Submitted Dataset
MESA, AZ / ACCESS Newswire / November 2, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced that updated internal evaluation results for MDCE Melanoma Scan Beta have been posted on the Company's corporate website.
The full technical summary is available at https://www.medicalcaretechnologies.com.
This release fulfills the Company's October 20 announcement that next-round results on the expanded human-submitted dataset would be published. The evaluation covers the same three technical layers previously described:
- Image intake and quality scoring - 86% of newly submitted user photographs met the internal usability threshold and advanced to further processing (held-out samples were primarily limited by extreme blur, severe underexposure, or incomplete framing).
- Body-map registration - 89% of usable images were successfully placed on the interactive body map with sufficient landmark consistency to support later retrieval of the same skin area.
- Change-over-time comparison - 91% of paired sequential images of a previously mapped area achieved alignment sufficient for side-by-side visual review under the Company's internal protocol.
These figures are drawn from the larger set of human-submitted images collected after the September 29 first-pass results. The first pass had confirmed that real-world photographs could move through the three layers. The current readout reflects continued testing against lighting, device, distance, angle, and compression variables that public archives (HAM10000, ISIC, TCIA) do not fully represent.
Sample internal metrics from the expanded set (controlled sequential captures):
Layer | Metric | Result | Notes |
|---|---|---|---|
| Image quality | Usability pass rate | 86% | Above typical 75-82% range reported for unconstrained smartphone skin images in published consumer-capture studies |
| Body-map | Successful registration | 89% | Landmark consistency sufficient for re-identification of mapped area |
| Sequential comparison | Alignment completion | 91% | Paired images suitable for visual change review |
| Overall workflow | End-to-end completion | 84% | Percentage of submissions that completed all three layers without manual intervention |
MDCE Melanoma Scan Beta remains in beta-stage development. It has not received regulatory clearance and is not intended to treat, cure, or prevent any disease or medical condition. It is not a substitute for professional medical advice, screening, or evaluation by a qualified healthcare provider. The results describe internal technical evaluation of image handling, mapping, and comparison only.
"The expanded set produced higher usability and registration numbers than the first pass," said Marshall Perkins, CEO of Medical Care Technologies. "These are internal technical results on photographs people actually take. Intake remains open so we can keep widening the test set."
Volunteer participation is not a clinical diagnosis program and is not a clinical efficacy trial. Any concern about a skin change should be reviewed by a licensed clinician.
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. Visit: https://www.medicalcaretechnologies.com
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.
Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: marshall@medicalcaretechnologies.com
Website: https://www.medicalcaretechnologies.com
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for November
3 of the Best Dividend Stocks to Own
The 10 Best Companies to Invest in Now
These Overvalued Stocks Have Plenty of Room to Fall
United States